Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Hansen%2C+Doris+K%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Hansen%2C+Doris+K%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Hansen%2C+Doris+K%22&type=Person&sort=year
PubPharm (26)
1
Applying the EHA/EBMT grading for ICAHT after CAR-T : comparative incidence and association with infections and mortality
enthalten in:
Blood advances
| 2024
von
Rejeski, K.
|
Wang, Y.
|
Hansen, D.
| +14
Wird geladen...
2
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
enthalten in:
Blood cancer journal
| 2024
von
Afrough, A.
|
Hashmi, H.
|
Hansen, D.
| +27
Wird geladen...
3
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy
enthalten in:
Transplantation and cellular therapy
| 2024
von
Akhtar, O.
|
Modi, K.
|
Kim, J.
| +18
Wird geladen...
4
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
enthalten in:
Haematologica
| 2024
von
Sidana, S.
|
Peres, L.
|
Hashmi, H.
| +28
Wird geladen...
5
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy
enthalten in:
Blood advances
| 2024
von
Peres, L.
|
Oswald, L.
|
Dillard, C.
| +31
CommentIn: Blood Adv. 2024 Jan 9;8(1):248-250. - PMID 38194242
Wird geladen...
6
The Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer : A Systematic Literature Review
enthalten in:
Cancers
| 2023
von
Hansen, D.
|
Liu, Y.
|
Ranjan, S.
| +5
Wird geladen...
7
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma : U.S. Myeloma Immunotherapy Consortium real world experience
enthalten in:
Haematologica
| 2023
von
Hashmi, H.
|
Hansen, D.
|
Peres, L.
| +23
Wird geladen...
8
Impact of weight and creatinine adjustments on the accuracy of Cockcroft-gault equation in hematopoietic cell transplant patients
enthalten in:
Clinical transplantation
| 2023
von
Emanuel, N.
|
Price, S.
|
Hansen, D.
| +3
Wird geladen...
9
Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel
enthalten in:
Cancers
| 2023
von
Oswald, L.
|
Gudenkauf, L.
|
Li, X.
| +19
Wird geladen...
10
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma
enthalten in:
Blood advances
| 2023
von
Lee, D.
|
Kumar, A.
|
Mohammed, T.
| +25
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
26
Aufsätze
25
E-Artikel
25
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
5
Blood advances
4
Annals of hematology
3
Cancers
3
Journal of hematology & oncology
2
Blood cancer journal
2
Haematologica
2
Transplantation and cellular therapy
1
Best practice & research. Clinical haematology
1
Clinical transplantation
1
Journal of clinical oncology : official journal...
1
Journal of patient experience
1
Seminars in oncology
Alle anzeigen ...
weniger ...
Thema
20
Journal Article
9
Multiple myeloma
8
Receptors, Chimeric Antigen
7
Research Support, Non-U.S. Gov't
5
8PX1X7UG4D
5
idecabtagene vicleucel
4
Immunomodulatory agents
4
Monoclonal antibodies
4
Proteasome inhibitors
4
Relapsed/Refractory
4
Research Support, N.I.H., Extramural
4
Review
4
Selinexor
3
B-Cell Maturation Antigen
3
BCMA CAR-T
3
Chimeric antigen receptor
3
Cytopenias
3
Hematological toxicity
3
Infections
3
Multicenter Study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2024
11
2023
8
2022
2
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...